Bengaluru, 22 September 2021: Milann, one of the largest fertility and birthing care providers in collaboration with HCG Cancer Hospital Bengaluru, today organized an awareness talk on ovarian cancer, its symptoms, early detection and treatment as well as fertility preservation in cancer patients on the occasion of Gynaecological Cancer Awareness Month. While the talk on ovarian cancer was addressed by Dr. Nisha Buchade, Consultant – Gynaec Oncology, HCG Cancer Hospital, Dr. Vyshnavi Rao, Consultant – Reproductive Medicine, Milann Fertility & Birthing Centre addressed on fertility preservation in cancer patients.
The event witnessed around 60 people attending besides joining through google meet. The talk was followed by an interactive session where the patients’ queries were cleared related to ovarian cancer and fertility preservation. The session helped the patients make an informed decision on whether they would like themselves tested and the importance of early detection of ovarian cancer.
Addressing the audience, Dr. Nisha Buchade, Consultant – Gynaec Oncology, HCG Cancer Hospital Bengaluru said, “With the increasing incidences of women being affected by Ovarian Cancer in India, we need to take constructive steps in creating awareness about detection of ovarian cancer at an early stage. Women need to know their family medical history and genetic factors as they play an important role in ovarian cancer. Up to 10 per cent of women having family history of fallopian tube cancer, ovarian cancer, and peritoneal cancer, should undergo genetic testing for mutation in the BRCA1 and BRCA2 gene. It is one of the deadliest gynecologic cancers and spreading awareness about it is very crucial. The best treatment is prevention.
Any cancers that begin in women’s reproductive organs are called gynecological cancers. Gynecological cancers are one of the leading causes of cancer-related deaths in women worldwide. In fact, ovarian cancer is the third most common gynaecological cancer in women and is responsible for most of the deaths that occur due to gynaecological cancers in the world. However, there is a lack of awareness in the world when it comes to gynaecological cancers.
Speaking on the occasion, Dr. Vyshnavi Rao, Consultant – Reproductive Medicine, Milann Fertility & Birthing Centre, Bengaluru said, “Today, cancer patients not only have a better rate of survival but can also think of parenthood and starting a family. Cancer treatment can affect fertility in both men and women. However, there are many techniques like egg freezing, embryo freezing, donor eggs, donor embryos, donor sperms and sperm freezing which can help in preserving fertility. However, unfortunately, most of the times, fertility preservation techniques are not even discussed with the patient before starting cancer therapy. Radiation oncologists should refer patients to reproductive specialists at the earliest, given the fact that they encounter multiple patients.”
Fertility preservation is a technique where the sperms, eggs or embryos are preserved for future use in the IVF treatment. The process involves freezing of sperms prior to beginning chemotherapy or radiotherapy besides freezing of extra embryos obtained from the IVF cycle. While both chemotherapy and radiotherapy can be damaging to the ovary depending on the agent used, dose given, and age of the patient, techniques like Ovarian Transposition (involves physically moving the ovaries out of the pelvis through operational methods) have been proven to be efficient in fertility preservation in women. However, fertility preservation is not just about eggs and sperms. In fact, it is about fulfilling the dreams of patients suffering from cancers and cancer survivors who also desire of parenthood.
About Milann Fertility & Birthing Centre:
Established in 1990, Milann was formerly known as Bangalore Assisted Conception Centre (BACC). The company was re-branded as Milann when it entered a strategic partnership with Health Care Global Enterprise Limited (HCGEL) in 2013 and became a 100% HCGEL subsidiary in 2020. With 8 centres spread across India at prime locations, Milann has been helping thousands of couples become parents while establishing benchmarks in technology, training and clinical competence in the field of Maternity, Antenatal Care, Gynaecology & Infertility. Since its inception, Milann has always been at the forefront of scientific research, giving comprehensive care to patients with access to a whole range of advanced reproductive services and state-of-the-art technologies. A five-time winner of the “Best in Fertility Services” award by the Times of India, Milann has some of the other feathers to its cap including the ET Best Healthcare Award 2021.
About HealthCare Global Enterprises Ltd.
HealthCare Global Enterprises Ltd (HCG), is one of the largest providers of cancer care in India. Through its network of 22 comprehensive cancer centers across India and Africa, HCG has brought advanced cancer care to the doorstep of millions of people. HCG’s comprehensive cancer centers provide expertise and advanced technologies required for the effective diagnosis and treatment of cancer under one roof. Under the “Milann” brand, HCG operates 7 fertility centers. Strand Life Sciences, an associate company of HCG, is a precision diagnostics company with strong track record in bioinformatics and a pioneer of genomic testing in India.